Swiggy share price fell 7.4% after reporting a third-quarter loss of ₹799.08 crore. Total expenses increased significantly, ...

The IPO is a complete Offer for Sale (OFS), with promoter Carlyle selling its stake. After the IPO, Carlyle's ownership will ...

Stay informed with the Grasim Inds Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a leading stock. Get the latest details on Grasim Inds, including: Last ...

Management expects double-digit revenue growth for the NFB segment in 2025 despite some short-term supply constraints in Q1 affecting Pro AV managed switch products. The company plans to expand its ...

Shares in Northern Solar Holdings Bhd surged 42.85% over its initial public offering (IPO) price on its first day of trading ...

In the previous session, Sensex dropped 312.53 points, or 0.40 per cent, to close at 78,271.28, while Nifty50 ended lower by ...

South Korea’s biggest new listing in more than two years got off to a weak start as LG CNS Co. fell on its Seoul trading ...

Trump Media & Technology Group (DJT), a conglomerate synonymous with the Trump brand, is a stock tethered to President Donald ...

Ategrity Specialty Insurance Co., a provider of excess and surplus insurance to small and midsize US companies, is exploring ...

Beta Bionics (BBNX) leads innovation in the diabetes treatment market with its groundbreaking iLet Bionic Pancreas technology ...

After a burst of oil and gas M&A deals, demand for new investment targets and buoyant natural-gas prices are helping drive a rebound in IPO activity in the energy industry to start 2025.

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.